Abstract

Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus

Author(s): Zur Eyal

Issue: Sep/Oct 2019 - Volume 23, Number 5

Page(s): 376-381

Download in electronic PDF format for $75
  • Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus Page 1
  • Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus Page 2
  • Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus Page 3
  • Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus Page 4
  • Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus Page 5
  • Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus Page 6

Note: Electronic version includes supplemental material.

Abstract

Barrett's esophagus refers to an abnormal change in the cells of the lower portion of the esophagus. It is characterized by the replacement of the normal stratified squamous epithelium lining of the esophagus by columnar epithelium cells which are usually found lower in the gastrointestinal tract. The medical significance of this pathology is approximately 0.5% risk to develop esophageal adenocarcinoma (per patient diagnosed with Barrett's esophagus per year). Diagnosis requires endoscopy and biopsy. In general, high-grade dysplasia and early stages of adenocarcinoma can be treated by endoscopic resection and/or endoscopic ablative therapy, whereas advanced stages (submucosal) are generally advised to undergo surgical treatment. Patients who undergo endoscopic resection and/or endoscopic ablative therapy might suffer from retrosternal discomfort and transient dysphagia, adverse effects that sometimes accompanies these procedures. One of the common post-procedural treatments is sucralfate 1 g 3 to 4 times daily for two weeks after the procedure. The rational for this treatment is to enhance the wound-healing process in the esophagus tissues and to coat the wounded tissues with a cytoprotective agent. As no clinical trials have been performed in order to prove the efficacy of sucralfate in the postprocedural treatment of Barrett's esophagus, this article summarizes the clinical experience accumulated from the treatment with sucralfate as a wound-healing enhancer. In addition, the article deals with the hypothesized mechanism of action of sucralfate and gives one option for compounding sucralfate oral viscous gel.

Related Keywords

  • Barrett esophagus
  • columnar epithelium
  • high-grade dysplasia
  • endoscopic therapy
  • adenocarcinoma risk factor
  • surgical wound healing
  • mucoadhesive sucralfate preparations
  • gastrointestinal reflux disease
  • GERD
  • viscous adhesive preparations
  • mucosal ulcers
  • mucosal erosion
  • formulations

Related Categories

  • FORMULATIONS
  • GASTROENTEROLOGY
  • WOUND CARE
  • UNITED STATES PHARMACOPEIA CONVENTIONS
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2019
Pg. 376-381
Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus
Author(s): Zur Eyal
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Jan/Feb 2009
Pg. 25-29
Compounding with Sucralfate for the Treatment of External Wounds
Author(s): Wynn Tom, Williams LaVonn A
Mar/Apr 2002
Pg. 92-95
Options in Wound Care
Author(s): Kincaid Michele R
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Jul/Aug 2008
Pg. 359
Sucralfate and Hyaluronic Acid Ointment
Author(s): Allen Loyd V Jr
Jul/Aug 2012
Pg. 288-293
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide
Author(s): Zur Eyal
Nov/Dec 2022
Pg. 480-488
A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing
Author(s): Riepl Mike
Jul/Aug 2020
Pg. 282-285
Compounding Pearls -- Wound Care: Burn Healing, Part 2
Author(s): Riepl Mike
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Sep/Oct 2021
Pg. 372-377
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Author(s): Riepl Mike
Sep/Oct 2004
Pg. 354-357
Current Topical Treatments in Wound Healing - Part 2
Author(s): Helmke Christopher D
Jan/Feb 2018
Pg. 60-65
Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing
Author(s): Song Guiyun, Banov Daniel, Bassani August S
May/Jun 2020
Pg. 188-193
Compounding Pearls -- Wound Care: Burn Healing, Part 1
Author(s): Riepl Mike
Jan/Feb 2013
Pg. 74-85
View Sample
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Jul/Aug 2021
Pg. 282-287
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2
Author(s): Riepl Mike
May/Jun 2024
Pg. 260-263
Case Report on the Effect of AlpaWash® on the Healing of a Post-surgical Wound in a Female Canine Initially Diagnosed with Pyometra
Author(s): Semighini Flávia, Fornaciari Laís de Azevedo, Haiub Halema, Pinheiro Vanessa, Lupatini Rodrigo, Cull Erica
Jan/Feb 2019
Pg. 14-21
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 2
Author(s): Williams LaVonn A
Jul/Aug 2018
Pg. 284-287
The History, Symptoms, Causes, Risk Factors, Types, Diagnosis, Treatments, and Prevention of Gout, Part 1
Author(s): Williams LaVonn
Jul/Aug 2020
Pg. 278-281
Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 2
Author(s): Riepl Mike